Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
500-mg Versus 1000-mg Ceftriaxone for Uncomplicated Gonorrhea Infection
NCT07710118Phase 3Recruiting
- Sponsor
- National Taiwan University Hospital
- Start
- Jul 2026
- Primary completion
- Dec 2028
- Countries
- 1
01
Overview
A Phase 3 trial of ceftriaxone in gonorrhea, sponsored by National Taiwan University Hospital. Started Jul 2026; status: recruiting.
02
Drugs
ceftriaxone
03
Conditions
gonorrhea
Beyond the preview
Go deeper on NCT07710118.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07710118.